Research

Impressionism and the modernization of time

A new book from history of art professor André Dombrowski knits together the works of artists like Claude Monet and the nature of time as it emerges in its present-day form.

From OMNIA

A hopeful time for Cryptosporidium research

Boris Striepen of Penn Vet organized the First Biennial Cryptosporidium Meeting, bringing together researchers and clinicians from around the world to discuss the problems and progress around the parasite and the diarrheal disease it causes.

Erica Moser



In the News


CNN

There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that

A 2020 study from the Perelman School of Medicine found that a blood test to screen for certain biomarkers associated with pancreatic cancer was 92% accurate in its ability to detect disease.

FULL STORY →



Fortune

Hedge funder famous for his ‘black swan’ strategy says there’s ‘something immoral’ about America’s reliance on debt—and future generations ‘will bear the burden for this’

A 2023 study by the Wharton School found that the U.S. has about 20 years left for corrective action to fix the national debt before it hits 200% of GDP.

FULL STORY →



Kiplinger

Can money buy you happiness? Yes, it can. However…

Research by Matthew Killingsworth of the Wharton School reveals there is no monetary threshold at which money's capacity to improve well-being diminishes.

FULL STORY →



Newsweek

Sugar-coated gold nanoparticles could replace some antibiotics

According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.

FULL STORY →



New Scientist

Alzheimer’s may be caused by a build-up of fat in brain cells

A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.

FULL STORY →



Associated Press

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.

FULL STORY →